Simplex Trading, LLC Avadel Pharmaceuticals PLC Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$2.57 - $7.31 $5,397 - $15,351	2,100 New	2,100 $10,000
Q2 2018 Jul 30, 2018	SELL	$5.89 - $7.78 $1,478 - $1,952	-251 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$6.76 - $11.7 $4,279 - $7,406	-633 Reduced 71.61%	251 $1,000
Q4 2017 Jan 10, 2018	BUY	$8.03 - $11.25 $7,098 - $9,945	884	884 $7,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $661M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.